Antiviral protection following immunization correlates with humoral but not cell-mediated immunity. (Q44033919)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20066003%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

title

Antiviral protection following immunization correlates with humoral but not cell-mediated immunity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20066003%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20066003%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Gunasegaran Karupiah

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20066003%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

Geeta Chaudhri

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20066003%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

language of work or name

1 reference

12 January 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20066003%20AND%20SRC:MED&resulttype=core&format=json

Immunology & Cell Biology

16 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20066003%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

88

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20066003%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

461-467

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20066003%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20066003%20AND%20SRC:MED&resulttype=core&format=json

Smallpox vaccination: a review, part II. Adverse events

16 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.110

Obligatory requirement for antibody in recovery from a primary poxvirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.110

Polarized type 1 cytokine response and cell-mediated immunity determine genetic resistance to mousepox

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.110

Type 1 and type 2 cytokines in antiviral defense.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.110

Antibodies and CD8+ T cells are complementary and essential for natural resistance to a highly lethal cytopathic virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.110

Interferon function is not required for recovery from a secondary poxvirus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.110

Protective immunity against secondary poxvirus infection is dependent on antibody but not on CD4 or CD8 T-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.110

Immunization with a single extracellular enveloped virus protein produced in bacteria provides partial protection from a lethal orthopoxvirus infection in a natural host

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.110

Memory CD8+ T cells are gatekeepers of the lymph node draining the site of viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.110

Immunological memory and protective immunity: understanding their relation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.110

Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.110

Ectromelia virus: the causative agent of mousepox

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.110

GROWTH OF ECTROMELIA VIRUS IN THE LIVER PARENCHYMAL CELLS OF DIFFERENT STRAINS OF MOUSE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.110

Memory B cell development but not germinal center formation is impaired by in vivo blockade of CD40-CD40 ligand interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.110

Distinctive characteristics of germinal center B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.110

Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.110

T cell avidity determines the level of CTL activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.110

High-avidity CTL exploit two complementary mechanisms to provide better protection against viral infection than low-avidity CTL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.110

T cell receptor sharing by cytotoxic T lymphocytes facilitates efficient virus control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.110

Cytokines and immunity to viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.110

Diversity of epitope and cytokine profiles for primary and secondary influenza a virus-specific CD8+ T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.110

Functional differences between memory and naive CD8 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.110

Activated and memory CD8+ T cells can be distinguished by their cytokine profiles and phenotypic markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.110

Response of naïve and memory CD8+ T cells to antigen stimulation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.110

Effective post-exposure protection against lethal orthopoxviruses infection by vaccinia immune globulin involves induction of adaptive immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.110

Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.110

Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.110

Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.110

Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.110

Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.110

Duration of humoral immunity to common viral and vaccine antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.110

Antibodies and B cell memory in viral immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.110

Duration of antiviral immunity after smallpox vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.110

Infertility in mice induced by a recombinant ectromelia virus expressing mouse zona pellucida glycoprotein 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.110

The nonreplicating smallpox candidate vaccines defective vaccinia Lister (dVV-L) and modified vaccinia Ankara (MVA) elicit robust long-term protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.110

Different roles for CD4+ and CD8+ T lymphocytes and macrophage subsets in the control of a generalized virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.110

7 January 2021

Identification of nitric oxide synthase 2 as an innate resistance locus against ectromelia virus infection.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.110

7 January 2021

Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.110

7 January 2021

Short- and long-term immunogenicity and protection induced by non-replicating smallpox vaccine candidates in mice and comparison with the traditional 1st generation vaccine

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.110

7 January 2021